Marvel Biosciences Corp. (MRVL.V)
CAD 0.16
(10.34%)
CAD 0.16
(10.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 887.51 Thousand | 1.37 Million | 613.09 Thousand | 265.2 Thousand | - |
| Gross Profit | -887.51 Thousand | -1.37 Million | -613.09 Thousand | -265.2 Thousand | - |
| Operating Expenses | 2.31 Million | 1.17 Million | 485.04 Thousand | 689.57 Thousand | 100.04 Thousand |
| Selling, General and Administrative Expenses | 1.4 Million | 1.11 Million | 635.26 Thousand | 750.9 Thousand | 100.04 Thousand |
| Research and Development Expenses | 887.51 Thousand | 1.37 Million | 613.09 Thousand | 265.2 Thousand | - |
| Other Expenses | - | - | -35 Thousand | - | - |
| Cost and Expenses | 2.31 Million | 2.54 Million | 1.09 Million | 954.77 Thousand | 100.04 Thousand |
| Operating Income | -2.31 Million | -2.54 Million | 806.33 Thousand | -954.2 Thousand | -100.05 Thousand |
| Interest Expense | 34.59 Thousand | 1549.00 | 1968.00 | 719.00 | - |
| Income Tax Expense | - | 5860.00 | 1.9 Million | 886.00 | -171.86 Thousand |
| Earnings before Tax | -2.29 Million | -2.55 Million | -3.03 Million | -955.65 Thousand | -98.04 Thousand |
| Net Income | -2.29 Million | -2.55 Million | -3.03 Million | -955.65 Thousand | -98.04 Thousand |
| Earnings Per Share Basic | -0.06 | -0.08 | -0.17 | -0.13 | -0.03 |
| Earnings Per Share Diluted | -0.06 | -0.08 | -0.17 | -0.13 | -0.03 |
| Weighted Average Shares Outstanding | 39.66 Million | 32.75 Million | 17.69 Million | 7.37 Million | 2.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.66 Million | 32.75 Million | 17.69 Million | 7.37 Million | 2.98 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -2.25 Million | -2.5 Million | -1.24 Million | -1.01 Million | -100.05 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 30.04 Thousand | 43.51 Thousand | 211.66 Thousand | 887.51 Thousand | 618.53 Thousand | 254.36 Thousand |
| Gross Profit | -30.04 Thousand | -43.51 Thousand | -211.66 Thousand | -887.51 Thousand | -618.53 Thousand | -254.36 Thousand |
| Operating Expenses | 237.74 Thousand | 208.48 Thousand | 228.07 Thousand | 1.36 Million | 417.4 Thousand | 437.85 Thousand |
| Selling, General and Administrative Expenses | 207.7 Thousand | 180.39 Thousand | 222.68 Thousand | - | 429.3 Thousand | 396.13 Thousand |
| Research and Development Expenses | 30.04 Thousand | - | 211.66 Thousand | - | 618.53 Thousand | 254.36 Thousand |
| Other Expenses | 11.6 Thousand | - | - | - | - | - |
| Cost and Expenses | 237.74 Thousand | 252 Thousand | 439.74 Thousand | 2.24 Million | 1.03 Million | 692.21 Thousand |
| Operating Income | -237.74 Thousand | -252 Thousand | -439.74 Thousand | -2.25 Million | -1.03 Million | -692.84 Thousand |
| Interest Expense | 35.05 Thousand | 22.45 Thousand | 20.7 Thousand | 34.59 Thousand | 12.15 Thousand | 22.43 Thousand |
| Income Tax Expense | -228.69 Thousand | - | -22.56 Thousand | -133.3 Thousand | -31.65 Thousand | 62.01 Thousand |
| Earnings before Tax | -307.31 Thousand | -232.81 Thousand | -518.29 Thousand | -2.29 Million | -1.04 Million | -716.32 Thousand |
| Net Income | -307.31 Thousand | -232.81 Thousand | -518.29 Thousand | -2.29 Million | -1.04 Million | -716.32 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | - | -0.03 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | - | -0.03 | -0.02 |
| Weighted Average Shares Outstanding | 39.78 Million | 39.78 Million | 39.78 Million | 39.66 Million | 39.78 Million | 39.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.78 Million | 39.78 Million | 39.78 Million | 39.66 Million | 39.78 Million | 39.78 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -237.74 Thousand | -252 Thousand | -439.74 Thousand | - | -1.03 Million | -692.84 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
HOOD
CRS
PMHG
LIVN
CATG
PX